Back

A Territory-wide study of COVID-19 cases and clusters with unknown source in Hong Kong community: A clinical, epidemiological and phylogenomic investigation

Leung, K. S.-S.; Ng, T. T.-L.; Wu, A. K.-L.; Yau, M. C.-Y.; Lao, H.-Y.; Choi, M.-P.; Tam, K. K.-G.; Lee, L.-K.; Wong, B. K.-C.; Ho, A. Y.-M.; Yip, K.-T.; Lung, K.-C.; Liu, R. W.-T.; Tso, E. Y.-K.; Leung, W.-S.; Chan, M.-C.; Ng, Y.-Y.; Sin, K.-M.; Fung, K. S.-C.; Chau, S. K.-Y.; To, W.-K.; Que, T.-L.; Shum, D. H.-K.; Yip, S. P.; Yam, W.-C.; Siu, G. K. H.

2020-03-31 infectious diseases
10.1101/2020.03.30.20045740 medRxiv
Show abstract

Initial cases of COVID-19 reported in Hong Kong were mostly imported from China. However, most cases reported in February 2020 were locally-acquired infections, indicating local community transmissions. We extracted the demographic, clinical and epidemiological data from 50 COVID-19 patients, who accounted for 53.8% of the cases in Hong Kong by February 2020. Whole-genome sequencing of the SARS-CoV-2 were conducted to determine the phylogenetic relatedness and transmission dynamics. Only three (6.0%) patients required ICU admission. Phylogenetic analysis identified six transmission clusters. All locally-acquired cases harboured a common mutation Orf3a G251V and were clustered in two subclades in global phylogeny of SARS-CoV-2. The estimated time to the most recent common ancestor of local COVID-2019 outbreak was December 24, 2019 with an evolutionary rate of 3.04x10-3 substitutions per site per year. The reproduction number value was 1.84. Social distancing and vigilant epidemiological control are crucial to the containment of COVID-19 transmission. Article summary linesA combined epidemiological and phylogenetic analysis of early COVID-19 outbreak in Hong Kong revealed that a SARS-CoV-2 variant with ORF3a G251V mutation accounted for all locally acquired cases, and that asymptomatic carriers could be a huge public health risk for COVID-19 control.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
The Lancet Infectious Diseases
71 papers in training set
Top 0.2%
9.2%
2
eLife
5422 papers in training set
Top 8%
8.5%
3
Nature Communications
4913 papers in training set
Top 22%
8.5%
4
International Journal of Infectious Diseases
126 papers in training set
Top 0.1%
6.9%
5
The Lancet Regional Health - Western Pacific
15 papers in training set
Top 0.1%
6.4%
6
Emerging Microbes & Infections
74 papers in training set
Top 0.2%
4.9%
7
Scientific Reports
3102 papers in training set
Top 31%
4.0%
8
Emerging Infectious Diseases
103 papers in training set
Top 0.5%
4.0%
50% of probability mass above
9
Science China Life Sciences
26 papers in training set
Top 0.4%
3.6%
10
Journal of Medical Virology
137 papers in training set
Top 1%
2.7%
11
Frontiers in Medicine
113 papers in training set
Top 3%
2.1%
12
Journal of Infection
71 papers in training set
Top 1%
1.9%
13
Frontiers in Public Health
140 papers in training set
Top 4%
1.8%
14
Clinical Infectious Diseases
231 papers in training set
Top 3%
1.7%
15
PLOS Medicine
98 papers in training set
Top 3%
1.5%
16
Microbiology Spectrum
435 papers in training set
Top 3%
1.5%
17
mBio
750 papers in training set
Top 8%
1.3%
18
iScience
1063 papers in training set
Top 21%
1.2%
19
The Journal of Infectious Diseases
182 papers in training set
Top 3%
1.2%
20
Cell Discovery
54 papers in training set
Top 4%
1.2%
21
Science
429 papers in training set
Top 17%
1.1%
22
Frontiers in Genetics
197 papers in training set
Top 7%
1.0%
23
PLOS ONE
4510 papers in training set
Top 66%
0.8%
24
Signal Transduction and Targeted Therapy
29 papers in training set
Top 1%
0.8%
25
PLOS Pathogens
721 papers in training set
Top 9%
0.8%
26
Eurosurveillance
80 papers in training set
Top 2%
0.8%
27
Travel Medicine and Infectious Disease
15 papers in training set
Top 0.7%
0.7%
28
Genomics, Proteomics & Bioinformatics
171 papers in training set
Top 6%
0.7%
29
Genome Medicine
154 papers in training set
Top 8%
0.7%
30
Frontiers in Microbiology
375 papers in training set
Top 10%
0.6%